Cargando…
Neutrophils as emerging protagonists and targets in chronic inflammatory diseases
INTRODUCTION: Neutrophils are the key cells of our innate immune system with a primary role in host defense. They rapidly arrive at the site of infection and display a range of effector functions including phagocytosis, degranulation, and NETosis to eliminate the invading pathogens. However, in rece...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607713/ https://www.ncbi.nlm.nih.gov/pubmed/36289077 http://dx.doi.org/10.1007/s00011-022-01627-6 |
_version_ | 1784818614182871040 |
---|---|
author | Rawat, Kavita Shrivastava, Anju |
author_facet | Rawat, Kavita Shrivastava, Anju |
author_sort | Rawat, Kavita |
collection | PubMed |
description | INTRODUCTION: Neutrophils are the key cells of our innate immune system with a primary role in host defense. They rapidly arrive at the site of infection and display a range of effector functions including phagocytosis, degranulation, and NETosis to eliminate the invading pathogens. However, in recent years, studies focusing on neutrophil biology have revealed the highly adaptable nature and versatile functions of these cells which extend beyond host defense. Neutrophils are now referred to as powerful mediators of chronic inflammation. In several chronic inflammatory diseases, their untoward actions, such as immense infiltration, hyper-activation, dysregulation of effector functions, and extended survival, eventually contribute to disease pathogenesis. Therefore, a better understanding of neutrophils and their effector functions in prevalent chronic diseases will not only shed light on their role in disease pathogenesis but will also reveal them as novel therapeutic targets. METHODS: We performed a computer-based online search using the databases, PubMed.gov and Clinical trials.gov for published research and review articles. RESULTS AND CONCLUSIONS: This review provides an assessment of neutrophils and their crucial involvement in various chronic inflammatory disorders ranging from respiratory, neurodegenerative, autoimmune, and cardiovascular diseases. In addition, we also discuss the therapeutic approach for targeting neutrophils in disease settings that will pave the way forward for future research. |
format | Online Article Text |
id | pubmed-9607713 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-96077132022-10-28 Neutrophils as emerging protagonists and targets in chronic inflammatory diseases Rawat, Kavita Shrivastava, Anju Inflamm Res Review INTRODUCTION: Neutrophils are the key cells of our innate immune system with a primary role in host defense. They rapidly arrive at the site of infection and display a range of effector functions including phagocytosis, degranulation, and NETosis to eliminate the invading pathogens. However, in recent years, studies focusing on neutrophil biology have revealed the highly adaptable nature and versatile functions of these cells which extend beyond host defense. Neutrophils are now referred to as powerful mediators of chronic inflammation. In several chronic inflammatory diseases, their untoward actions, such as immense infiltration, hyper-activation, dysregulation of effector functions, and extended survival, eventually contribute to disease pathogenesis. Therefore, a better understanding of neutrophils and their effector functions in prevalent chronic diseases will not only shed light on their role in disease pathogenesis but will also reveal them as novel therapeutic targets. METHODS: We performed a computer-based online search using the databases, PubMed.gov and Clinical trials.gov for published research and review articles. RESULTS AND CONCLUSIONS: This review provides an assessment of neutrophils and their crucial involvement in various chronic inflammatory disorders ranging from respiratory, neurodegenerative, autoimmune, and cardiovascular diseases. In addition, we also discuss the therapeutic approach for targeting neutrophils in disease settings that will pave the way forward for future research. Springer International Publishing 2022-10-26 2022 /pmc/articles/PMC9607713/ /pubmed/36289077 http://dx.doi.org/10.1007/s00011-022-01627-6 Text en © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2022, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Review Rawat, Kavita Shrivastava, Anju Neutrophils as emerging protagonists and targets in chronic inflammatory diseases |
title | Neutrophils as emerging protagonists and targets in chronic inflammatory diseases |
title_full | Neutrophils as emerging protagonists and targets in chronic inflammatory diseases |
title_fullStr | Neutrophils as emerging protagonists and targets in chronic inflammatory diseases |
title_full_unstemmed | Neutrophils as emerging protagonists and targets in chronic inflammatory diseases |
title_short | Neutrophils as emerging protagonists and targets in chronic inflammatory diseases |
title_sort | neutrophils as emerging protagonists and targets in chronic inflammatory diseases |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607713/ https://www.ncbi.nlm.nih.gov/pubmed/36289077 http://dx.doi.org/10.1007/s00011-022-01627-6 |
work_keys_str_mv | AT rawatkavita neutrophilsasemergingprotagonistsandtargetsinchronicinflammatorydiseases AT shrivastavaanju neutrophilsasemergingprotagonistsandtargetsinchronicinflammatorydiseases |